Always up to date.
 

Our goal is to develop procedure and anatomy specific devices that lead in collaboration with our customers to predictable and superior treatment outcomes. Read on to learn more about our solutions, priorities, partnerships and how we create sustainable value with our teams.

New Scaphoid System for APTUS Hand*

The new Scaphoid System 1.5-3.0 sets new standards: Additional scaphoid plates and a dedicated container - including CCS – offer extended options for the treatment of scaphoid non-unions and...

Read more

Medartis shareholders approve all proposals at the AGM 2024

The shareholders of Medartis Holding AG (SIX: MED) today approved all the substantive proposals of the Board of Directors with a clear majority of more than 94.8%. All members of the Board of...

Read more

Medartis successfully places CHF 115.8 million convertible bonds due 2031

Medartis Holding AG (SIX: MED, the “Company” or “Medartis”), a specialized orthopaedic company for head and extremity surgery, announces the successful placement of senior unsecured guaranteed...

Read more